Linalool |
C57BL/6J mice fed with HFD |
Lowers TC, TG, and LDL-C, and improves atherogenic index |
Suppresses SREBP-2-mediated HMG-CoA reductase expression and induces ubiquitin-dependent proteolysis of the HMG-CoA reductase |
[24] |
Amarogentin |
C57BL/6J mouse model of diabetes |
Attenuates neointimal thickening, and collagen and lipid deposition in the aorta, lowers TC, TG, LDL-C, and VLDL-C, and increases HDL-C |
Induces phosphorylation of AMPK |
[26] |
Oleuropein |
Wistar rats fed with a cholesterol rich diet |
Decreases TC and TG, and elevates HDL-C |
Suppresses lipid synthesis and promotes fatty acid oxidation mediated by AMPK |
[27] |
Aucubin |
C57BL/6J mice treated with tyloxapol |
Downregulates TC, TG, LDL-C and VLDL-C, and increases HDL-C |
Activates AMPK and Nrf2, and promotes the expression of PPARα and PPARγ |
[28] |
Thymoquinone |
SD rats fed with HFD |
Decreases TC and LDL-C levels |
Downregulates gene expression of HMG-CoA reductase and upregulates the expression LDLR |
[30] |
Geniposide |
C57BL/6J mice and ApoE−/− mice fed with HFD |
Suppresses atherosclerotic plaque progression, reduces serum TC and TG, and attenuates hepatic lipid deposition |
Regulates FXR-mediated liver-gut crosstalk of bile acids |
[31] |
Swertiamarin |
SD rats fed with a cholesterol rich diet |
Lowers TC, TG, LDL-C, VLDL-C, and atherogenic index |
Inhibits HMG-CoA reductase activity and enhances the fecal bile acid and total sterols excretion |
[34] |
Eucalyptol |
Wistar rat model of diabetic-atherosclerosis |
Prevents the formation of the atheromatous lesions, reduces TC, TG, and LDL-C, and upregulates HDL-C |
Not shown |
[35] |
Geraniol |
Syrian hamsters fed with an atherogenic diet |
Decreases TC, TG, free fatty acids, phospholipids, LDL-C, and VLDL-C, upregulates HDL-C, and lowers atherogenic index |
Inhibits HMG-CoA reductase and suppresses lipogenesis |
[36] |
Thymol |
New Zealand white rabbits fed with HFD |
Decreases TC, TG, and LDL-C, and elevates HDL-C |
Not shown |
[37] |
Limonene |
Wistar rats fed with an atherogenic diet |
Reduces TG, TC, VLDL-C, LDL-C and non-HDL-C levels, and elevates HDL-C/LDL-C, HDL-C/TC and HDL-C/TG |
Reduces HMG-CoA reductase activity |
[38] |
p-Cymene |
Wistar rat model of diabetes |
Improves TC, TG, LDL-C, VLDL-C, and HDL-C |
Suppresses AKT/mTOR signaling |
[39] |
Safranal |
Wistar rat model of diabetes |
Decreases total lipids, TC, TG, and LDL-C, and elevates HDL-C |
Not shown |
[40] |
Genipin |
C57BL/6J mice fed with HFD; mouse primary hepatocytes treated with free fatty acids |
Antagonizes HFD-induced hyperlipidemia and hepatic lipid accumulation |
Regulates miR-142a-5p/SREBP-1c axis |
[41] |
Catalpol |
New Zealand white rabbits fed with HFD and EA. hy926 cells treated with ox-LDL |
Attenuates atherosclerotic lesions, decreases TC, TG, and LDL-C, and increases HDL-C |
Promotes Nrf2/HO-1-mediated anti-oxidative stress and inhibits NF-κB-mediated inflammation |
[42] |
Paeoniflorin |
C57BL/6J mice fed with HFD |
Exerts an antagonistic effect on hyperlipidemia and lipid ectopic deposition |
Lowers the lipid synthesis pathway, promotes fatty acid oxidation and increases cholesterol output |
[43] |
Loganic acid |
New Zealand rabbits fed with a cholesterol rich diet |
Decreases intima thickness and intima/media ratio in the thoracic aorta, lowers TG and ox-LDL, and increases HDL-C |
Promotes the expression of PPARα and PPARγ |
[44] |
Loganin |
C57BLKS/J type 2 diabetic db/db mice |
Reduces TG and LDL-C/VLDL-C, and increases HDL-C |
Suppresses gene expressions related to lipid synthesis and adjusts the abnormal expression of PPARα and SREBPs in the nucleus |
[45] |
Oleacein |
C57BL/6J mice fed with HFD |
Reduces TC, TG, and LDL-C |
Downregulates the expression of FAS, SREBP-1, and phospho-ERK |
[46] |
Gentiopicroside |
C57BL/6J mice treated with tyloxapol and HepG2 cells treated with free fatty acid |
Reduces TC and TG |
Regulates Nrf2-mediated PPARα activation and SREBP-1c inactivation |
[47] |